Heart rate variability in coronary artery disease

Journal of Internal Medicine

Volumn 237, Issue 4, 1995, Pages 349-357

  HUIKURI, H V ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AMBULATORY MONITORING; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAM; HEART MUSCLE ISCHEMIA; HEART RATE AND RHYTHM; HUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0028926563     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.1995.tb01186.x     Document Type: Review

References (55)

1. Time domain measurements of heart rate variability
2. Heart rate variability. Frequency domain analysis
3. Heart rate variability and clinical cardiology
4. Power spectral analysis of heart rate fluctuation: a quantitative probe of beat‐to‐beat cardiovascular control
5. Cardiovascular neural regulation explored in the frequency domain
6. Comparison of time and frequency domain‐based measures of cardiac parasympathetic activity in Holter recordings after myocardial infarction
7. Frequency domain measures of heart period variability and mortality after myocardial infarction
8. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interaction in man and conscious dog
9. Assessment of autonomic function in humans by heart rate spectral analysis
10. Decreased magnitude of heart rate spectral components in coronary artery disease: its relation to angiographic severity
11. Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects
12. Is the normal heart a periodic oscillator
13. Chaos and fractals in human physiology
14. Correlation dimension of heartbeat intervals is reduced in conscious pigs by myocardial ischemia
15. Applications of fractal analysis to physiology
16. Frequency‐response characteristics of vascular resistance vessels
17. An analysis of the nonlinear behaviour of the human thermal vasomotor control system
18. A non‐invasive method for testing neural circulatory control in man
19. Components of heart rate variability – what they really mean and what we really measure
20. Components of heart rate variability measured during healing of acute myocardial infarction
21. Cardiac parasympathetic activity during the early hours of acute myocardial infarction
22. Heart rate variability in acute myocardial infarction and its association with infarct size and clinical course
23. Temporary decrease in cardiac parasympathetic tone after myocardial infarction
24. Early heart rate variability alterations after acute myocardial infarction
25. Early heart rate variability during the acute phase of myocardial infarction
26. Determinants of frequency domain measures of heart rate variability in the acute and convalescent phase of myocardial infarction
27. Heart rate variability as an index of sympathovagal interaction in patients after myocardial infarction
28. Time course of recovery of heart period variability after myocardial infarction
29. Changes in frequency domain measures of heart rate variability in relation to the onset of ventricular tachycardia in acute myocardial infarction
30. Impaired vagal heart rate control in coronary artery disease
31. Effects of chronic myocardial infarction on vagal cardiopulmonary baroreflex
32. Aging of modulation of heart rate
33. Effect of atenol and diltiazem on heart period variability in normal persons
34. Effect of beta‐blockade on heart rate variability in patients with coronary artery disease
35. Circadian rhythms of frequency domain measures of heart rate variability in healthy subjects and patients with coronary artery disease: effects of arousal and upright and upright posture
36. Reproducibility and circadian rhythm of heart rate variability in healthy subjects
37. Continuous 24‐hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects
38. Activation of left ventricular receptors with non‐medullated vagal afferent fibers during occlusion of a coronary artery in the cat
39. Nervous activity of afferent cardiac sympathetic fibers with atrial and ventricular endings
40. Correlation dimension of heartbeat intervals is reduced in conscious pigs by myocardial ischemia
41. Responses of heart rate variability to coronary occlusion during coronary angioplasty
42. Effect of pre‐occlusion stenosis severity on heart rate reactions to coronary occlusion
43. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
44. Correlation of heart rate variability with clinical and angiographic variables and lale mortality after coronary angiography
45. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal‐averaged electrocardiogram
46. Heart rate variability from 24‐hour electrocardiography and the 2‐year risk for sudden death
47. Relation between heart rate variability early after acute myocardial infarction and long‐term mortality
48. Frequency domain measures of heart period variability to assess risk of late myocardial infarction
49. Frequency domain measures of heart rate variability before the onset of nonsustained and sustained ventricular tachycardia in patients with coronary artery disease
50. Nonlinear dynamics in sudden death syndrome: heartrate oscillations and bifurcations
51. Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction
52. Sustained augmentation of parasympathetic tone with angiotensin‐converting enzyme inhibition in patients with congestive heart failure
53. Influence of physical training on heart rate variability and baroreflex circulatory control
54. Heart rate after coronary artery bypass grafting
55. Vagal heart rate control after percutaneous transluminal coronary angioplasty